Business Standard

Centre allows Bharat Biotech to begin commercial exports of Covaxin

Bharat Biotech made 55 million doses of Covaxin in October, and aims to make 80 million doses in December.

Bharat Biotech, Covaxin
Premium

Photo: Shutterstock

Sohini Das Mumbai
Paving the way for commercial exports of Covid-19 vaccines to start from India, the Centre allowed Hyderabad-based vaccine maker Bharat Biotech to start commercial exports of Covaxin on Tuesday, according to sources in the know. 

A few days back, its peer Pune’s Serum Institute of India (SII), was allowed to export to the WHO-led vaccine initiative COVAX.

Bharat Biotech did not wish to comment on the matter. SII, too, did not confirm if it got a nod to start commercial bilateral exports from the Indian government.

Bharat Biotech made 55 million doses of Covaxin in October, and aims to make 80 million doses

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 25 2021 | 6:10 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com